arrow6 Comments
  1. [...] to the Patent Baristas, the USPTO’s decision was based on two main prior art references: (a) U.S. Pat. No. 5,166,065 [...]

  2. [...] WARF Stem Cell Patents Knocked Down in Round One   [...]

  3. [...] WARF Stem Cell Patents Knocked Down in Round One  [...]

  4. [...] seems to be on a roll after successfully getting reexams of patents on Pfizer’s Lipitor, WARF’s stem cells., and Gilead [...]

  5. [...] In another challenge to patents it just doesn’t like, the nonprofit organization Public Patent Foundation (PUBPAT) got the U.S. Patent and Trademark Office (USPTO) to grant a request for reexamination of four key HIV/AIDS drug patents held by Gilead Sciences Inc. PUBPAT seems to be on a roll after successfully getting reexams of patents on Pfizer’s Lipitor and WARF’s stem cells. [...]

  6. [...] Then, the California Biotech Law Blog and Patent Baristas present the fall of the Wisconsin Alumni Research Foundation’s stem cell patent claims. [...]

Mobile Theme